REGISTERED
on 05 Dec 2023
Last Applicant/ Owned by
Rietlistrasse 4
Staad
CH
9422
Serial Number
97648621 filed on 26th Oct 2022
Registration Number
7234847 registered on 05th Dec 2023
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
BIOSYNTH
Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and mo Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics
First Use Date in General
08th Sep 2022
First Use Date in Commerce
08th Sep 2022
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of medicines and diagnostics for others; Custom manufacturing for others in the pharmaceutical, diagnostic, veterinary, biotechnology and chemistry fields
First Use Date in General
08th Sep 2022
First Use Date in Commerce
08th Sep 2022
Class [039]
Transportation & Storage Services
Packaging and filling articles to the order and specification of others; Warehouse services
First Use Date in General
08th Sep 2022
First Use Date in Commerce
08th Sep 2022
Class [005]
Pharmaceutical Products
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
First Use Date in General
08th Sep 2022
First Use Date in Commerce
08th Sep 2022
Class [001]
Chemical Products
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
First Use Date in General
08th Sep 2022
First Use Date in Commerce
08th Sep 2022
Mark Details
Serial Number
No 97648621
Mark Type
No Service Mark
Attorney Docket Number
No 09799037-tbd
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
| 05th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 19th Sep 2023 | PUBLISHED FOR OPPOSITION |
| 19th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 30th Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 09th Aug 2023 | ASSIGNED TO EXAMINER |
| 10th Nov 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 09th Nov 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 29th Oct 2022 | NEW APPLICATION ENTERED |